Economical value of vaccines for the developing countries--the case of Instituto Butantan, a public institution in Brazil
- PMID: 22140586
- PMCID: PMC3226538
- DOI: 10.1371/journal.pntd.0001300
Economical value of vaccines for the developing countries--the case of Instituto Butantan, a public institution in Brazil
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Miyaki C, Meros M, Precioso A, Raw I. Influenza vaccine production for Brazil: A classic example of successful Noth-South bilateral technology transfer. Vaccine. 2011;29(Suppl 1):A12–A15. - PubMed
-
- Watanabe M, Nagai M. Acellular pertussis vaccines in Japan: past, present and future. Expert Rev Vaccines. 2005;4:173–184. - PubMed
-
- Miyaki C, Quintilio W, Miyaji EN, Botosso VF, Kubrusly FS, et al. Production of H5N1 (NIBRG-14) inactivated whole virus and split virion influenza vaccines and analysis of immunogenicity in mice using different adjuvant formulations. Vaccine. 2010;28:2505–2509. - PubMed
-
- Quintilio W, Kubrusly FS, Iourtov D, Miyaki C, Sakauchi MA, et al. Bordetella pertussis monophosphoryl lipid A as adjuvant for inactivated split virion influenza vaccine in mice. Vaccine. 2009;27:4219–4224. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
